New perspectives in searching diagnostic markers for ovarian endometriosis

Мұқаба

Дәйексөз келтіру

Толық мәтін

Ашық рұқсат Ашық рұқсат
Рұқсат жабық Рұқсат берілді
Рұқсат жабық Рұқсат ақылы немесе тек жазылушылар үшін

Аннотация

Objective: Determination of expression levels of molecular genetic markers to improve the diagnosis of ovarian endometriosis (OE) and define prognostic criteria for recurrence and possible malignant transformation.

Materials and methods: Expression levels of lncRNAs in 30 and 25 cases of ovarian endometriotic cysts and ovarian adenocarcinomas, respectively, as well as in 25 cases in the control group, were studied using molecular genetic testing.

Results: Persistent increase in lncRNA MALAT1 expression level was found with the disease progression, and consistent increase and reduction of Linc-ROR expression level in the control group and in the group of patients with adenocarcinoma. For differential diagnosis of normal condition and OE, OE and adenocarcinoma, ROC curves for lncRNA expression levels were constructed, and important rule was derived to determine the histological status of the surgical material.

Conclusion: According to the results of expression levels of lncRNA markers MALAT1 and Linc-ROR in the groups of patients with endometriosis, adenocarcinoma and in the control group, the assessment of their potential possibility for predicting these conditions was suggested. Further targeted research in this area is necessary to develop new prognostic markers for endometriosis-associated ovarian cancer and search for additional therapeutic targets.

Толық мәтін

Рұқсат жабық

Авторлар туралы

Sergey Levakov

I.M. Sechenov First Moscow State Medical University, Ministry of Health of Russia (Sechenov University)

Email: levakoff@yandex.ru
ORCID iD: 0000-0002-4591-838X

Dr. Med. Sci., Professor, Head of the Department of Obstetrics and Gynecology, ICM named after N.V. Sklifosovsky

Ресей, 119991, Moscow, Trubetskaya str., 8-2

Tatyana Gromova

I.M. Sechenov First Moscow State Medical University, Ministry of Health of Russia (Sechenov University)

Хат алмасуға жауапты Автор.
Email: tgromova928@yandex.ru
ORCID iD: 0000-0001-6104-9842

PhD, Assistant of the Department of Obstetrics and Gynecology, ICM named after N.V. Sklifosovsky

Ресей, 119991, Moscow, Trubetskaya str., 8-2

Aynur Mamedova

I.M. Sechenov First Moscow State Medical University, Ministry of Health of Russia (Sechenov University)

Email: tgromova928@yandex.ru
ORCID iD: 0000-0002-9642-4523

post-graduate student of the Department of Obstetrics and Gynecology, ICM named after N.V. Sklifosovsky

Ресей, 119991, Moscow, Trubetskaya str., 8-2

Nadezhda Antipova

Academicians M.M. Shemyakin and Yu.A. Ovchinnikov Institute of Bioorganic Chemistry, Russian Academy of Sciences

Email: tgromova928@yandex.ru
ORCID iD: 0000-0002-5799-7767

PhD, Senior Researcher at the Laboratory of Membrane and Bioenergetic Systems

Ресей, Moscow, GSP-7, Miklukho-Maklaya str., 16/10

Әдебиет тізімі

  1. Andrew W.H., Stacey A.M. Pathophysiology, diagnosis, and management of endometriosis. BMJ. 2022; 379: e070750. https//dx.doi.org/10.1136/ bmj-2022-070750.
  2. Coloma J.L., Martínez-Zamora M.A., Collado A., Gràcia M., Rius М., Quintas L. et al. Prevalence of fibromyalgia among women with deep infiltrating endometriosis. Int. J. Gynaecol. Obstet. 2019; 146: 157-63. https//dx.doi.org/10.1002/ijgo.12822.
  3. Адамян Л.В., Протасова А.Э., Асатурова А.В., Раскин Г.А. Эндометриоз-ассоциированные заболевания, эндометриоз и рак:что общего? Проблемы репродукции. 2022; 28(1): 65-74. [Adamyan L.V., Protasova A.E., Asaturova A.V., Raskin G.A. Endometriosis-associated diseases, endometriosis and cancer: what is in common? Russian Journal of Human Reproduction. 2022; 28(1): 65-74. (in Russian).] https//dx.doi.org/10.17116/repro20222801165.
  4. Shafrir A.L., Palmor M.C., Fourquet J., DiVasta A.D., Farland L.V., Vitonis A.F. et al. Co-occurrence of immune-mediated conditions and endometriosis among adolescents and adult women. Am. J. Reprod. Immunol. 2021; 86: e13404. https//dx.doi.org/10.1111/aji.13404 PMID: 33583078.
  5. Enabi E., Khazaei S. Endometriosis and migraine headache risk: a meta-analysis. Women Health. 2020; 60: 939-45. https//dx.doi.org/10.1080/03630242.2020.1779905.
  6. Harris H.R., Korkes KM.N., Li T., Kvaskoff М., Cho Е., Carvalho L.F. et al. Endometriosis, psoriasis, and psoriatic arthritis: a prospective cohort study. Am. J. Epidemiol. 2022; 191(6): 1050-60. https//dx.doi.org/10.1093/aje/kwac009.
  7. Kvaskoff M., Mahamat-Saleh Y., Farland L.V., Shigesi N., Terry K.L., Harris H.R. et al. Endometriosis and cancer: a systematic review and meta-analysis. Hum. Reprod. Update. 2021; 27(2): 393-420. https//dx.doi.org/10.1093/humupd/dmaa045.
  8. Давыдов А.И., Михалева Л.М., Пацап О.И. К вопросу о маркерах ранней детекции эдометриоз-ассоциированных опухолей яичника. Вопросы гинекологии, акушерства и перинатологии. 2019; 18(4): 133-7. [Davydov A.I., Mihalyova L.M., Pacap O.I. On markers of early detection of endometriosis-associated ovarian tumors. Gynecology, Obstetrics and Perinatology. 2019; 18(4): 133-7. (in Russian).] https//dx.doi.org/10.20953/ 1726-1678-2019-4-133-137.
  9. Farland L.V., Degnan W.J.3rd., Bell M.L., Kasner S.E., Liberman A.L., Shah D.K. et al. Laparoscopically confirmed endometriosis and risk of incident stroke: a prospective cohort study. Stroke. 2022; 53(10): 3116-22. https//dx.doi.org/10.1161/STROKEAHA.122.039250 PMID: 35861076.
  10. Жорданиа К.И., Паяниди Ю.Г., Сонова М.М., Савостикова М.В., Баринов В.В., Калиничева Е.В. Эндометриоз и рак яичников. Продолжение темы. Онкогинекология. 2015: 2: 16-24. [Zhordania K.I., Payanidi Yu.G., Sonova M.M., Savostikova M.V. Endometriosis and ovarian cancer. Continuing the theme. Oncogynecology. 2015; (2): 16-24.]
  11. Shafrir A.L., Farland L.V., Shah D.K., Harris H.R., Kvaskoff M., Zondervan K. et al. Risk for and consequences of endometriosis: A critical epidemiologic review. Best Pract. Res. Clin. Obstet. Gynaecol. 2018; 51: 1-15. https//dx.doi.org/ 10.1016/j.bpobgyn.2018.06.001.
  12. Kanduri C. Long noncoding RNAs: Lessons from genomic imprinting. Biochim. Biophys. Acta. 2016; 1859(1): 102-11. https//dx.doi.org/10.1016/ j.bbagrm.2015.05.006.
  13. Mapanga W., Girdler-Brown B., Singh E. Knowledge, attitudes and practices of young people in Zimbabwe on cervical cancer and HPV, current screening methods and vaccination. BMC Cancer. 2019; 19(1): 845. https//dx.doi.org/ 10.1186/s12885-019-6060-z.
  14. Tan Y.T., Lin J.F., Li T., Li J.J., Xu R.H., Ju H.Q. LncRNA-mediated posttranslational modifications and reprogramming of energy metabolism in cancer. Cancer Communications. 2021; 41(2): 109-20. https//dx.doi.org/ 10.1002/cac2.12108.
  15. Kuang Y., Shen W., Zhu H., Huang H., Zhou Q., Yin W. The role of lncRNA just proximal to XIST (JPX) in human disease phenotypes and RNA methylation: The novel biomarker and therapeutic target potential. Biomed. Pharmacother. 2022; 155:113753. https//dx.doi.org/10.1016/ j.biopha.2022.113753.
  16. Yu J., Chen L.H., Zhang B., Zheng Q.M. The modulation of endometriosis by lncRNA MALAT1 via NF-κB/iNOS. Eur. Rev. Med. Pharmacol. Sci. 2019; 23(10): 4073-80. https//dx.doi.org/10.26355/eurrev_201905_17908.
  17. Mai H., Wei Y., Yin Y., Huang S., Lin H., Liao Y. et al. LINC01541 overexpression attenuates the 17β-Estradiol-induced migration and invasion capabilities of endometrial stromal cell. Syst. Biol. Reprod. Med. 2019; 65(3): 214-22. https//dx.doi.org/10.1080/19396368.2018.1549290.
  18. Jiang M.C., Ni J.J., Cui W.Y., Wang B.Y., Zhuo W. Emerging roles of lncRNA in cancer and therapeutic opportunities. Am. J.Ccancer Res. 2019; 9(7): 1354-66.
  19. Stelzle D., Tanaka L.F., Lee K.K., Khalil A.I., Baussano I., Shah A.S.V. et. al. Estimates of the global burden of cervical cancer associated with HIV. Lancet Glob. Health. 2021; 9(2): e161-9. https//dx.doi.org/10.1016/ S2214-109X(20)30459-9.
  20. Wilusz J.E. Long noncoding RNAs: Re-writing dogmas of RNA processing and stability. Biochim. Biophys. Acta. 2016; 1859(1): 128-38. https//dx.doi.org/ 10.1016/j.bbagrm.2015.06.003.
  21. Yoshimoto R., Mayeda A., Yoshida M., Nakagawa S. MALAT1 long non-coding RNA in cancer. Biochim. Biophys. Acta. 2016; 1859(1): 192-9. https//dx.doi.org/10.1016/j.bbagrm.2015.09.012.
  22. Liu J., Peng W.X., Mo Y.Y., Luo D. MALAT1-mediated tumorigenesis. Front. Biosci. (Landmark Ed). 2017; 22(1): 66-80. https//dx.doi.org/10.2741/4472.
  23. Miao H., Wu F., Li Y., Qin C., Zhao Y., Xie M. et al. MALAT1 modulates alternative splicing by cooperating with the splicing factors PTBP1 and PSF. Sci. Adv. 2022; 23; 8(51): eabq7289. https//dx.doi.org/10.1126/sciadv.abq7289.
  24. Li Y., Liu Y.D., Chen S.L., Chen X., Ye D.S., Zhou X.Y. et.al. Downregulation of long non-coding RNA MALAT1 inhibits granulosa cell proliferation in endometriosis by up-regulating P21 via activation of the ERK/MAPK pathway. Mol. Hum. Reprod. 2019; 25(1): 17-29. https//dx.doi.org/10.1093/molehr/gay045.
  25. Liang Z., Chen Y., Zhao Y., Xu C., Zhang A., Zhang Q. et. al. MiR-200c suppresses endometriosis by targeting MALAT1 in vitro and in vivo. Stem. Cell. Res. Ther. 2017; 8(1): 251. https//dx.doi.org/10.1186/s13287-017-0706-z.
  26. Chiu H.S., Somvanshi S., Chen T.W., Sumazin P. Illuminating lncRNA function through target prediction. Methods Mol. Biol. 2021; 2372: 263-95. https//dx.doi.org/10.1007/978-1-0716-1697-0_22.
  27. Xu X.Y., Zhang J., Qi Y.H., Kong M., Liu S.A., Hu J.J. Linc-ROR promotes endometrial cell proliferation by activating the PI3K-Akt pathway. Eur. Rev. Med. Pharmacol. Sci. 2018; 22(8): 2218-25. https//dx.doi.org/10.26355/eurrev_201804_14807.
  28. Cho B.J., Choi Y.J., Lee M.J., Kim J.H., Son G.H., Park S.H. et. al. Classification of cervical neoplasms on colposcopic photography using deep learning. Sci. Rep. 2020; 10(1): 13652. https//dx.doi.org/10.1038/s41598-020-70490-4.
  29. Gatta L.A., Kuller J.A., Rhee E.H.J. Pregnancy outcomes following cervical conization or loop electrosurgical excision procedures. Obstet. Gynecol. Surv. 2017; 72(8): 494-9. https//dx.doi.org/10.1097/OGX.0000000000000468.
  30. Zeng J., Ma Y.X., Liu Z.H., Zeng Y.L. LncRNA SNHG7 contributes to cell proliferation, invasion and prognosis of cervical cancer. Eur. Rev. Med. Pharmacol. Sci. 2019; 23(21): 9277-85. https//dx.doi.org/10.26355/eurrev_201911_19420.

Қосымша файлдар

Қосымша файлдар
Әрекет
1. JATS XML
Жүктеу
2. Fig. 1. Expression level of lncRNA Linc-ROR in groups of prospective analysis

Жүктеу (799KB)
Метадеректер
3. Fig. 2. Expression level of lncRNA MALAT1 in groups of prospective analysis

Жүктеу (808KB)
Метадеректер
4. Fig. 3. ROC curves for the differential diagnosis of normal and endometriosis: for MALAT1 the area under the curve is 98%, for Linc-ROR - 100%

Жүктеу (791KB)
Метадеректер
5. Fig. 4. ROC curves for the differential diagnosis of normal and carcinoma: for MALAT1 the area under the curve is 98%, for Linc-ROR - 100%

Жүктеу (787KB)
Метадеректер
6. Fig. 5. ROC curves for the differential diagnosis of ESI and carcinoma: for MALAT1 the area under the curve is 27.9%, for LincROR - 70.8%

Жүктеу (813KB)
Метадеректер
7. Fig. 6. Scheme of factor analysis of the prospective analysis group

Жүктеу (131KB)
Метадеректер
8. Fig. 7. ROC curve for prognosis of endometriosis

Жүктеу (779KB)
Метадеректер
9. Fig. 8. ROC curve for prognosis of ovarian carcinoma

Жүктеу (788KB)
Метадеректер

© Bionika Media, 2024

Осы сайт cookie-файлдарды пайдаланады

Біздің сайтты пайдалануды жалғастыра отырып, сіз сайттың дұрыс жұмыс істеуін қамтамасыз ететін cookie файлдарын өңдеуге келісім бересіз.< / br>< / br>cookie файлдары туралы< / a>